IPO7 and familial pancreatic carcinoma: Besides, survival analysis was performed by two databases, including the Human Protein Atlas database2 and Oncolnc database.3 The results suggested that the prognosis of patients with IPO7 high expression was worse than that of the patients with low IPO7 expression (Figures 1C,D), indicating that it may be a potential prognostic biomarker of pancreatic cancer.